The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oshimi, Y.
Right arrow Articles by Miyazaki, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oshimi, Y.
Right arrow Articles by Miyazaki, S.

The Journal of Immunology, Vol 157, Issue 7 2909-2915, Copyright © 1996 by American Association of Immunologists

ARTICLES

Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells

Y Oshimi, S Oda, Y Honda, S Nagata and S Miyazaki
Department of Physiology, Tokyo Women's Medical College, Japan.

The cytotoxicity of NK cells has been thought to be mediated mainly by the perforin-dependent pathway. We investigated the involvement of Fas- mediated pathway in the killing activity of purified human CD3-, CD16+ NK cells. Fas ligand mRNA was expressed in freshly isolated NK cells. Apoptosis, which was identified by the fragmented chromatin in individual cells, was induced in the cells that expressed high levels of Fas via direct NK-to-target cell interaction or Ab-dependent cell- mediated cytotoxicity, even in Ca(2+)-free medium, in which perforin pores are known not to be formed. Apoptosis in both the presence and absence of external Ca2+ was inhibited by Fab of an anti-Fas mAb. Transfection of the Fas gene in target cells facilitated the induction of apoptosis, compared with the parental cell line. The function of the Fas-mediated pathway in the coexistence of the perforin-dependent pathway was examined in 10 cell lines expressing different levels of Fas by Ca2+ imaging and morphologic observation of single cells. With a certain boundary level, low or high levels of Fas expression in target cells were correlated to a great degree with either acute necrosis due to severe membrane damage after NK-target cell contact or apoptosis at a later period, respectively. We concluded that Fas ligand/Fas interaction is present and plays a significant role in the human NK cell-induced apoptosis.


This article has been cited by other articles:


Home page
 Anticancer ResHome page
Y. KAWAGUCHI, K. KONO, Y. MIZUKAMI, K. MIMURA, and H. FUJII
Mechanisms of Escape from Trastuzumab-mediated ADCC in Esophageal Squamous Cell Carcinoma: Relation to Susceptibility to Perforin-granzyme
Anticancer Res, June 1, 2009; 29(6): 2137 - 2146.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
H. Matsubara, M. Watanabe, T. Imai, Y. Yui, Y. Mizushima, Y. Hiraumi, Y. Kamitsuji, K.-i. Watanabe, K. Nishijo, J. Toguchida, et al.
Involvement of Extracellular Signal-Regulated Kinase Activation in Human Osteosarcoma Cell Resistance to the Histone Deacetylase Inhibitor FK228 [(1S,4S,7Z,10S,16E,21R)-7-Ethylidene-4,21-bis(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone]
J. Pharmacol. Exp. Ther., March 1, 2009; 328(3): 839 - 848.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
P. Y. Cohen, R. Breuer, and S. B. Wallach-Dayan
Thy1 Up-Regulates FasL Expression in Lung Myofibroblasts via Src Family Kinases
Am. J. Respir. Cell Mol. Biol., February 1, 2009; 40(2): 231 - 238.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A.-C. Iversen, P. S. Norris, C. F. Ware, and C. A. Benedict
Human NK Cells Inhibit Cytomegalovirus Replication through a Noncytolytic Mechanism Involving Lymphotoxin-Dependent Induction of IFN-{beta}
J. Immunol., December 1, 2005; 175(11): 7568 - 7574.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. A. Erdmann, Z.-G. Gao, U. Jung, J. Foley, T. Borenstein, K. A. Jacobson, and D. H. Fowler
Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo
Blood, June 15, 2005; 105(12): 4707 - 4714.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Lima, J. Almeida, A. G. Montero, M. d. A. Teixeira, M. L. Queiros, A. H. Santos, A. Balanzategui, A. Estevinho, M. d. C. Alguero, P. Barcena, et al.
Clinicobiological, Immunophenotypic, and Molecular Characteristics of Monoclonal CD56-/+dim Chronic Natural Killer Cell Large Granular Lymphocytosis
Am. J. Pathol., October 1, 2004; 165(4): 1117 - 1127.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
I. De Freitas, M. Fernandez-Somoza, E. Essenfeld-Sekler, and J. E. Cardier
Serum Levels of the Apoptosis-Associated Molecules, Tumor Necrosis Factor-{alpha}/Tumor Necrosis Factor Type-I Receptor and Fas/FasL, in Sepsis
Chest, June 1, 2004; 125(6): 2238 - 2246.
[Abstract] [Full Text] [PDF]

Home page
 Br J OphthalmolHome page
J G Crowston, L H Chang, J T Daniels, P T Khaw, and A N Akbar
T lymphocyte mediated lysis of mitomycin C treated Tenon's capsule fibroblasts
Br J Ophthalmol, March 1, 2004; 88(3): 399 - 405.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. Y. Koh, J. R. Ortaldo, B. R. Blazar, M. Bennett, and W. J. Murphy
NK-cell purging of leukemia: superior antitumor effects of NK cells H2 allogeneic to the tumor and augmentation with inhibitory receptor blockade
Blood, December 1, 2003; 102(12): 4067 - 4075.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
U. Jung, J. E. Foley, A. A. Erdmann, M. A. Eckhaus, and D. H. Fowler
CD3/CD28-costimulated T1 and T2 subsets: differential in vivo allosensitization generates distinct GVT and GVHD effects
Blood, November 1, 2003; 102(9): 3439 - 3446.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Brandi, M. Paiardini, B. Cervasi, C. Fiorucci, P. Filippone, C. De Marco, N. Zaffaroni, and M. Magnani
A New Indole-3-Carbinol Tetrameric Derivative Inhibits Cyclin-dependent Kinase 6 Expression, and Induces G1 Cell Cycle Arrest in Both Estrogen-dependent and Estrogen-independent Breast Cancer Cell Lines
Cancer Res., July 15, 2003; 63(14): 4028 - 4036.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
J. C. Lambert, Z. Zhou, and Y. J. Kang
Suppression of Fas-Mediated Signaling Pathway Is Involved in Zinc Inhibition of Ethanol-Induced Liver Apoptosis
Experimental Biology and Medicine, April 1, 2003; 228(4): 406 - 412.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
D. Vermijlen, D. Luo, C. J Froelich, J. P. Medema, J. A. Kummer, E. Willems, F. Braet, and E. Wisse
Hepatic natural killer cells exclusively kill splenic/blood natural killer-resistant tumor cells by the perforin/granzyme pathway
J. Leukoc. Biol., October 1, 2002; 72(4): 668 - 676.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Briard, D. Brouty-Boye, B. Azzarone, and C. Jasmin
Fibroblasts from Human Spleen Regulate NK Cell Differentiation from Blood CD34+ Progenitors Via Cell Surface IL-15
J. Immunol., May 1, 2002; 168(9): 4326 - 4332.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. S. Gourley, D. R. Patel, K. Nickerson, S.-C. Hong, and C.-H. Chang
Aberrant Expression of Fas Ligand in Mice Deficient for the MHC Class II Transactivator
J. Immunol., May 1, 2002; 168(9): 4414 - 4419.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. C. Byrd, S. Kitada, I. W. Flinn, J. L. Aron, M. Pearson, D. Lucas, and J. C. Reed
The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction
Blood, February 1, 2002; 99(3): 1038 - 1043.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
T. Suhara, H.-S. Kim, L. A. Kirshenbaum, and K. Walsh
Suppression of Akt Signaling Induces Fas Ligand Expression: Involvement of Caspase and Jun Kinase Activation in Akt-Mediated Fas Ligand Regulation
Mol. Cell. Biol., January 15, 2002; 22(2): 680 - 691.
[Abstract] [Full Text] [PDF]

Home page
 Neuro Oncol DukeHome page
C. D. Riffkin, A. Z. Gray, C. J. Hawkins, C.W. Chow, and D. M. Ashley
Ex vivo pediatric brain tumors express Fas (CD95) and FasL (CD95L) and are resistant to apoptosis induction
Neuro-oncol, October 1, 2001; 3(4): 229 - 240.
[Abstract] [PDF]

Home page
 J. Immunol.Home page
R. D. Pettersen, G. Bernard, M. K. Olafsen, M. Pourtein, and S. O. Lie
CD99 Signals Caspase-Independent T Cell Death
J. Immunol., April 15, 2001; 166(8): 4931 - 4942.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
K. J. Brill, Q. Li, R. Larkin, D. H. Canaday, D. R. Kaplan, W. H. Boom, and R. F. Silver
Human Natural Killer Cells Mediate Killing of Intracellular Mycobacterium tuberculosis H37Rv via Granule-Independent Mechanisms
Infect. Immun., March 1, 2001; 69(3): 1755 - 1765.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. S. Gourley and C.-H. Chang
Cutting Edge: The Class II Transactivator Prevents Activation-Induced Cell Death by Inhibiting Fas Ligand Gene Expression
J. Immunol., March 1, 2001; 166(5): 2917 - 2921.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. S. Joshi, S. R. Tarantolo, C. A. Kuszynski, and A. Kessinger
Antitumor Therapeutic Potential of Activated Human Umbilical Cord Blood Cells against Leukemia and Breast Cancer
Clin. Cancer Res., November 1, 2000; 6(11): 4351 - 4358.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Brandau, H. Suttmann, J. Riemensberger, U. Seitzer, J. Arnold, C. Durek, D. Jocham, H.-D. Flad, and A. Böhle
Perforin-mediated Lysis of Tumor Cells by Mycobacterium Bovis Bacillus Calmette-Guerin-activated Killer Cells
Clin. Cancer Res., September 1, 2000; 6(9): 3729 - 3738.
[Abstract] [Full Text]

Home page
 BloodHome page
C. Berthou, J.-F. Bourge, Y. Zhang, A. Soulie, D. Geromin, Y. Denizot, F. Sigaux, and M. Sasportes
Interferon-gamma -induced membrane PAF-receptor expression confers tumor cell susceptibility to NK perforin-dependent lysis
Blood, April 1, 2000; 95(7): 2329 - 2336.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. Sata, T. Suhara, and K. Walsh
Vascular Endothelial Cells and Smooth Muscle Cells Differ in Expression of Fas and Fas Ligand and in Sensitivity to Fas Ligand-Induced Cell Death : Implications for Vascular Disease and Therapy
Arterioscler Thromb Vasc Biol, February 1, 2000; 20(2): 309 - 316.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
K. Walsh and J. M. Isner
Apoptosis in inflammatory-fibroproliferative disorders of the vessel wall
Cardiovasc Res, February 1, 2000; 45(3): 756 - 765.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Kashii, R. Giorda, R. B. Herberman, T. L. Whiteside, and N. L. Vujanovic
Constitutive Expression and Role of the TNF Family Ligands in Apoptotic Killing of Tumor Cells by Human NK Cells
J. Immunol., November 15, 1999; 163(10): 5358 - 5366.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
J. E. CARDIER, T. SCHULTE, H. KAMMER, J. KWAK, and M. CARDIER
Fas (CD95, APO-1) antigen expression and function in murine liver endothelial cells: implications for the regulation of apoptosis in liver endothelial cells
FASEB J, November 1, 1999; 13(14): 1950 - 1960.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
M. J. Smyth, K. Y. T. Thia, E. Cretney, J. M. Kelly, M. B. Snook, C. A. Forbes, and A. A. Scalzo
Perforin Is a Major Contributor to NK Cell Control of Tumor Metastasis
J. Immunol., June 1, 1999; 162(11): 6658 - 6662.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
S. A. Roughton, R. R. Lareu, A. H. Bittles, and A. M. Dharmarajan
Fas and Fas Ligand Messenger Ribonucleic Acid and Protein Expression in the Rat Corpus Luteum during Apoptosis-Mediated Luteolysis
Biol Reprod, April 1, 1999; 60(4): 797 - 804.
[Abstract] [Full Text]

Home page
 JEMHome page
L. Zamai, M. Ahmad, I. M. Bennett, L. Azzoni, E. S. Alnemri, and B. Perussia
Natural Killer (NK) Cell-mediated Cytotoxicity: Differential Use of TRAIL and Fas Ligand by Immature and Mature Primary Human NK Cells
J. Exp. Med., December 21, 1998; 188(12): 2375 - 2380.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Trotta, K. A. Puorro, M. Paroli, L. Azzoni, B. Abebe, L. C. Eisenlohr, and B. Perussia
Dependence of Both Spontaneous and Antibody-Dependent, Granule Exocytosis-Mediated NK Cell Cytotoxicity on Extracellular Signal-Regulated Kinases
J. Immunol., December 15, 1998; 161(12): 6648 - 6656.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Bradley, A. Zeytun, A. Rafi-Janajreh, P. S. Nagarkatti, and M. Nagarkatti
Role of Spontaneous and Interleukin-2-Induced Natural Killer Cell Activity in the Cytotoxicity and Rejection of Fas+ and Fas- Tumor Cells
Blood, December 1, 1998; 92(11): 4248 - 4255.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
M. J. Smyth, J. M. Kelly, A. G. Baxter, H. Korner, and J. D. Sedgwick
An Essential Role for Tumor Necrosis Factor in Natural Killer Cell-mediated Tumor Rejection in the Peritoneum
J. Exp. Med., November 2, 1998; 188(9): 1611 - 1619.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. K. A. Bauer, M. Vogt, M. Los, J. Siegel, S. Wesselborg, and K. Schulze-Osthoff
Role of Reactive Oxygen Intermediates in Activation-induced CD95 (APO-1/Fas) Ligand Expression
J. Biol. Chem., April 3, 1998; 273(14): 8048 - 8055.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. A. Houghton, F. G. Harwood, and D. M. Tillman
Thymineless death in colon carcinoma cells is mediated via Fas signaling
PNAS, July 22, 1997; 94(15): 8144 - 8149.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. R. Green and C. F. Ware
Fas-ligand: Privilege and peril
PNAS, June 10, 1997; 94(12): 5986 - 5990.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Sieg, D. Smith, Z. Yildirim, and D. Kaplan
Fas ligand deficiency in HIV disease
PNAS, May 27, 1997; 94(11): 5860 - 5865.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.